XENIA PHARMA ApS: Financial statements 2023
CVR: 35529454
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
XENIA PHARMA ApS (CVR 35529454) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -18,941 and a net result of DKK -16,323 compared with DKK -51,320 the year before. Equity in the 2023 report amounted to DKK -35,094. The company had 1 employee in the financial year.
- Gross Profit
- DKK -18,941
- Profit/Loss
- DKK -16,323
- Equity
- DKK -35,094
- Total Assets
- DKK 41,981
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -19K | -16K | -35K | 1 |
| 2022 | - | -54K | -51K | -19K | - |
| 2021 | - | -27K | -28K | -19K | - |
| 2020 | - | -2K | -2K | -1K | - |
| 2019 | - | -3K | -3K | 789 | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
XENIA PHARMA ApS has published its annual report for 2022. Gross profit came to DKK -53,707, and the net result was DKK -51,320.
About XENIA PHARMA ApS
XENIA PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company is registered under the industry Dyrlægeaktiviteter. The management consists of Dorte Xenia Gram. The company is owned by Dorte Xenia Gram. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -28,827 and a net result of DKK -28,855 compared with DKK -18,952 the year before. Equity in the 2025 report amounted to DKK -46,501.